Suppr超能文献

血浆多不饱和脂肪酸与肾功能衰退

Plasma polyunsaturated fatty acids and the decline of renal function.

作者信息

Lauretani Fulvio, Semba Richard D, Bandinelli Stefania, Miller Edgar R, Ruggiero Carmelinda, Cherubini Antonio, Guralnik Jack M, Ferrucci Luigi

机构信息

Tuscany Regional Agency, Florence, Italy.

出版信息

Clin Chem. 2008 Mar;54(3):475-81. doi: 10.1373/clinchem.2007.095521. Epub 2008 Jan 17.

Abstract

BACKGROUND

Recent studies suggest an association between polyunsaturated fatty acids (PUFAs) and the development of chronic kidney disease. The aim of this study was to examine the relationship between PUFAs and renal function in older adults.

METHODS

We performed a cross-sectional and prospective analysis of 931 adults, > or = 65 years old, enrolled in the InCHIANTI study, a population-based cohort in Tuscany, Italy. Plasma PUFAs were measured at enrollment, and creatinine clearance was estimated by the Cockcroft-Gault equation at baseline and after 3-year follow-up.

RESULTS

At enrollment, participants with higher creatinine clearance had higher concentrations of HDL cholesterol, total plasma PUFAs, plasma n-3 fatty acid (FA), and plasma n-6 FA and lower triglycerides. From enrollment to the 3-year follow-up visit, creatinine clearance declined by 7.8 (12.2) mL/min (P <0.0001). Baseline total plasma PUFAs, n-3 FA, n-6 FA, and linoleic, linolenic, and arachidonic acids were strong independent predictors of less steep decline in creatinine clearance from baseline to follow-up (P <0.0001, after adjusting for baseline creatinine clearance). After adjusting for baseline creatinine, baseline total plasma PUFAs, n-3 FA, and linoleic, linolenic, and arachidonic acids were negatively associated with creatinine at 3-year follow-up. Participants with higher plasma PUFAs at enrollment had a lower risk of developing renal insufficiency, defined by a creatinine clearance <60 mL/min, during 3-year follow-up.

CONCLUSION

High PUFA concentrations, both n-3 FA and n-6 FA, may attenuate the age-associated decline in renal function among older community-dwelling women and men.

摘要

背景

近期研究表明多不饱和脂肪酸(PUFAs)与慢性肾脏病的发生之间存在关联。本研究旨在探讨老年人中PUFAs与肾功能之间的关系。

方法

我们对931名年龄≥65岁的成年人进行了横断面和前瞻性分析,这些成年人参与了InCHIANTI研究,该研究是意大利托斯卡纳地区一项基于人群的队列研究。在入组时测量血浆PUFAs,并在基线和3年随访后通过Cockcroft-Gault方程估算肌酐清除率。

结果

入组时,肌酐清除率较高的参与者具有较高的高密度脂蛋白胆固醇、血浆总PUFAs、血浆n-3脂肪酸(FA)和血浆n-6 FA浓度以及较低的甘油三酯水平。从入组到3年随访时,肌酐清除率下降了7.8(12.2)mL/分钟(P<0.0001)。基线血浆总PUFAs、n-3 FA、n-6 FA以及亚油酸、亚麻酸和花生四烯酸是从基线到随访期间肌酐清除率下降较缓的强有力独立预测因素(在调整基线肌酐清除率后,P<0.0001)。在调整基线肌酐后,基线血浆总PUFAs、n-3 FA以及亚油酸、亚麻酸和花生四烯酸在3年随访时与肌酐呈负相关。入组时血浆PUFAs较高的参与者在3年随访期间发生肾功能不全(定义为肌酐清除率<60 mL/分钟)的风险较低。

结论

高浓度的PUFAs,包括n-3 FA和n-6 FA,可能会减轻社区居住的老年女性和男性中与年龄相关的肾功能下降。

相似文献

1
Plasma polyunsaturated fatty acids and the decline of renal function.血浆多不饱和脂肪酸与肾功能衰退
Clin Chem. 2008 Mar;54(3):475-81. doi: 10.1373/clinchem.2007.095521. Epub 2008 Jan 17.
5
Plasma Levels of Polyunsaturated Fatty Acids and Adverse Kidney Outcomes.多不饱和脂肪酸的血浆水平与不良肾脏结局。
Am J Kidney Dis. 2024 Aug;84(2):179-194.e1. doi: 10.1053/j.ajkd.2023.12.020. Epub 2024 Feb 28.

引用本文的文献

1
Lipidomics-based natural products for chronic kidney disease treatment.基于脂质组学的用于慢性肾脏病治疗的天然产物
Heliyon. 2025 Jan 2;11(1):e41620. doi: 10.1016/j.heliyon.2024.e41620. eCollection 2025 Jan 15.
6
Nutrition, Immunology, and Kidney: Looking Beyond the Horizons.营养、免疫学与肾脏:展望未来
Curr Nutr Rep. 2022 Mar;11(1):69-81. doi: 10.1007/s13668-021-00388-8. Epub 2022 Jan 26.
7
Determinants of the Evolution of Kidney Function With Age.肾功能随年龄变化的决定因素。
Kidney Int Rep. 2021 Oct 16;6(12):3054-3063. doi: 10.1016/j.ekir.2021.10.006. eCollection 2021 Dec.

本文引用的文献

3
Sarcopenic obesity and inflammation in the InCHIANTI study.基安蒂研究中的肌少症性肥胖与炎症
J Appl Physiol (1985). 2007 Mar;102(3):919-25. doi: 10.1152/japplphysiol.00627.2006. Epub 2006 Nov 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验